O

OncoLens

17 employees

OncoLens replaces the current labor intensive process of patient case collaboration and subsequent CoC accreditation in cancer care.

Basic info

Industry

health, wellness & fitness

Sectors

Multidisciplinary Cancer Care
Trial Management Software
Lung Cancer
Cancer Conferences
Hematology
Tumor Boards
Director
Oncology
Healthcare Technology
Cancer Registrars
Breast Cancer
Clinical Trials
Commission on Cancer
Health Care
Colon Cancer
Accreditation Assistance
NAPBC
Cancer Research
Medical
Prostate Cancer
Oncology Services
Molecular Tumor Board
Information Technology

Date founded

2016

Funding rounds raised

Total raised

$7.3M

from 9 investors over 9 rounds

O

OncoLens raised undisclosed on July 13, 2023

Investors: Cross-Border Impact Ventures

O

OncoLens raised $7.3M on January 14, 2021

Investors: BIP CAPITAL and SeedtoB Capital

O

OncoLens raised $2.5M on January 6, 2020

Investors: BIP CAPITAL and Atlanta Technology Angels

O

OncoLens raised $1.4M on March 26, 2019

Investors: BIP CAPITAL and Atlanta Technology Angels

O

OncoLens raised $750K on February 14, 2019

Investors: BIP CAPITAL and Atlanta Technology Angels

FAQ